enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Grail (company) - Wikipedia

    en.wikipedia.org/wiki/Grail_(company)

    Their liquid biopsy (also called multi-cancer early detection test [4]) was launched in June 2021 and is called the Galleri test. Promoted as groundbreaking, the test performed poorly in testing and Grail has subsequently faced discontent and legal action from investors claiming they have been misled about the test's potential. [5]

  3. New colorectal cancer blood test approved by FDA: What to know

    www.aol.com/colorectal-cancer-blood-test...

    The Food and Drug Administration (FDA) has recently approved a blood test screening for colorectal cancer that has an over 83% success rate at detecting the presence of this form of cancer.

  4. Cancer screening - Wikipedia

    en.wikipedia.org/wiki/Cancer_screening

    In 2023 the FDA approved the first blood test for the detection of cancer, which identifies DNA variants in 47 genes associated with an elevated risk of hereditary cancer. [53] [54] This test is manufactured by Invitae. [53] Other tests on the market are multi-cancer early detection (MCED). [55]

  5. FDA approves new blood test to screen for colon cancer

    www.aol.com/news/fda-approves-blood-test-screen...

    The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating ...

  6. FDA approves blood test to detect colon cancer for those at ...

    www.aol.com/fda-approves-blood-test-detect...

    The U.S. Food and Drug Administration on Monday morning approved a blood test to screen for colorectal cancer in certain individuals. The blood test, known as Shield and manufactured by Guardant ...

  7. Exact Sciences Corp. - Wikipedia

    en.wikipedia.org/wiki/Exact_Sciences_Corp.

    Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer.

  8. FDA approves blood test for colorectal cancer screening among ...

    www.aol.com/news/fda-approves-blood-test...

    The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older.

  9. Pexidartinib - Wikipedia

    en.wikipedia.org/wiki/Pexidartinib

    In August 2019, it was approved by U.S. FDA for treatment of giant-cell tumor of the tendon sheath (GC-TS). [2] [6] [7] Pexidartinib is available in the US only through the Turalio Risk Evaluation and Mitigation Strategy (REMS) Program. [2] The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication. [8]